← Back to all trials
Recruiting
NCT07361120
Plan A Occlusion and Reversal System Feasibility Study
Conditions: Fertility, Fertility, Male, Healthy Male Adults
Sex: Male
Ages: 25 Years – 65 Years
Healthy volunteers: Yes
Phase: PHASE2
Enrollment: 40
Sponsor: Next Life Sciences
Location: Western Urology Maribyrnong Victoria
Summary
Prospective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive System to occlude the vas deferens to block the passage of sperm and then be reversed to subsequently allow the passage of sperm through the vas deferens.
Eligibility Criteria
Inclusion Criteria:
1. Male subject who is seeking and suitable to undergo a vasectomy as a long-term form of contraception
2. Male subject who has voluntarily signed and dated the Institutional Review Board (IRB)/Ethics Committee (EC) approved informed consent form (ICF) for this study prior to initiation of any screening or study specific procedures
3. 25 to 65 years of age at the time of consent
4. Body Mass Index (BMI) \
Source: ClinicalTrials.gov (NCT07361120). StuddyBuddy aggregates publicly available trial information.
